Atossa Therapeutics annual operating margin
2011
2012
2013
2014
2015
Atossa Therapeutics's operating margin was −725,746.19% for fiscal 2015.
View full Atossa Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2015 | 2015-12-31 | −725,746.19% | −695423.23 pp |
| 2014 | 2014-12-31 | −30,322.96% | −28618.03 pp |
| 2013 | 2013-12-31 | −1,704.93% | −652.91 pp |
| 2012 | 2012-12-31 | −1,052.01% | +227560.66 pp |
| 2011 | 2011-12-31 | −228,612.67% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2015 | 2015-12-31 | −140,656.43% | −130662.54 pp |
| Q4 2014 | 2014-12-31 | −122,680.24% | −116838.70 pp |
| Q3 2014 | 2014-09-30 | −94,724.31% | −90152.47 pp |
| Q2 2014 | 2014-06-30 | −32,268.69% | −31476.44 pp |
| Q1 2014 | 2014-03-31 | −9,993.89% | −8931.08 pp |
| Q4 2013 | 2013-12-31 | −5,841.54% | −4109.42 pp |
| Q3 2013 | 2013-09-30 | −4,571.85% | −3496.15 pp |
| Q2 2013 | 2013-06-30 | −792.25% | −269.69 pp |
| Q1 2013 | 2013-03-31 | −1,062.81% | +878.54 pp |
| Q4 2012 | 2012-12-31 | −1,732.12% | — |
| Q3 2012 | 2012-09-30 | −1,075.69% | — |
| Q2 2012 | 2012-06-30 | −522.56% | — |
| Q1 2012 | 2012-03-31 | −1,941.34% | — |
Across the available reported history, Atossa Therapeutics's operating margin decreased from −30,322.96% to −725,746.19%, a change of −695423.23 percentage points. The latest reported quarter, Q4 2015, shows −140,656.43%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atossa Therapeutics filings at SEC.gov ↗